Cart 0

KEY partnerships

leaders with a history of success are making history again.

 

As you’d expect, our team at Maricann has some of the most respected names in the cannabis industry. But what makes this team truly unique is these leaders are joined by professionals from healthcare, pharmaceutical manufacturing, distribution and global entrepreneurship. Each has earned a record of respect within their industries. And each brings their highly sought-after skills, insights and experience to this dynamic new sector. Every one of them is passionate about the power of cannabis, how it can advance healthcare and help real people. It’s a team like no other. 

 
 


 

executive team

 

BEN WARD

CEO,director

Ben leads all facets of the company’s operations, including its strategic direction and execution, finance and industry relations. He brings extensive domestic and global experience in business development, infrastructure development and capital markets to his leadership of Maricann. Ben holds a BA (Honors) and an MBA from Bradford University School of Management (England), the latter with a dual concentration in Operations and Finance.

Terry Fretz

president

A long-time pharmaceutical executive, Terry was integral in establishing and running two privately held generic pharmaceutical companies. Under his leadership, both organizations were recognized as the fastest growing pharma companies in Canada. Both companies were subsequently acquired by publicly traded multinationals. Terry served as President and General Manager of Watson Pharmaceuticals – Canada before assuming his responsibilities at Maricann.

James_500px.png

Dr. james Hyssen

COO

Dr. Hyssen, a physician by training - possesses an accomplished background as the co-founder of Douglas Laboratories, a globally recognized and distributed nutraceutical company. James will lead the company’s operations as it expands its product offering globally through recognized distribution channels, primarily pharmacy. 

 

DR. STEVEN Bennett

Chief Scientific officer

Dr. Bennett is a molecular biologist with a background in transdermal drug delivery. As Maricann’s Scientific Director, he sources and develops new products, ensuring their scientific and technical rigour. Steven holds two patents and has published several articles in peer-reviewed journals. He earned a B.Sc. in biochemistry from Eckerd College, and received his Ph.D. in molecular biology – with an emphasis on neuroscience – from The University of South Florida College of Medicine.

 
Scott_500px.png

Scott Langille

Chief Financial Officer

Scott has over 30 years of experience in the pharmaceutical industry in both Canada and the United States. Scott has held CFO positions at publicly traded pharmaceutical companies including Tribute Pharmaceuticals, and Virexx Medical Corp. Past financial experience includes Vice President at Biovail Pharmaceuticals Inc. and  Director, Corporate Finance at Biovail Corporation. Scott has a professional accounting designation and an MBA from the University of Toronto.

Thomas.png

Dr. Thomas Klumpp, Ph.D.

Qualified Person –
European Operations

Dr. Klumpp joins the Maricann team after a 27-year term with Bayer, holding senior positions within the corporation including, Manager of CC Production, Africa, Asia, Australia; Head of Production in the Bitterfeld manufacturing facility (manufacture of 9 billion plus capsules per year). Thomas completed his Ph.D. at the University of Bonn – Centre of Pharmaceutical Technology and is licensed to practice Pharmacy in Germany.

DR. Alexandre Sibilev

Regulatory affairs and compliance officer

Dr. Sibilev has worked in the pharmaceutical sector for over 20 years, with experience in quality control, quality assurance, regulatory affairs and compliance. Alex ensures quality medication is provided to patients that is consistent, reliable and safe for consumption. Alex holds a PhD in Pharmaceutical Sciences from Moscow State University.

 

directors

Bios_Template_Round.png

Neil Tabatznik

Chairman & Director

Chairman of Genpharm Pharmaceuticals Inc. between 1993 and 1999, Neil then created Arrow Canada and was Director of the Arrow Group of Companies, consisting of Oryx Pharmaceuticals Inc. and Cobalt Pharmaceuticals Inc. Neil is Chairman of Blue Ice Capital and Blue Ice Pictures, founder of the Blue Ice Hot Docs Documentary Film Fund, and owner of The Bloor-Hot Docs Theatre.

Gerhard_500px(1).png

Gerhard Müller

Director

Past audit partner of Ernst and Young’s German practice, responsible partner for the Technology, Media & Entertainment sector at Ernst & Young for the Germany, Switzerland, Austria (GSA) Region. A Certified Public Auditor and Tax consultant, Mr. Müller studied economics and English in Munich and Manchester (UK). He left Ernst & Young in 2013 and has been working in his own practice since then. Since July 1, 2013, Mr. Müller has also been deputy chairman of Habitat for Humanity in Germany. Gerhard is an independent member of the company’s Board of Directors.

FPO.png

raymond Stone

Corporate Secretary & Director

Raymond founded Futuremed Healthcare Products, a healthcare distribution company, in 1985. Futuremed was listed on the Toronto Stock Exchange in 2006 and Raymond served as CEO until its sale in 2012 to Cardinal Health, a global healthcare corporation based in the USA. Raymond currently consults to the healthcare industry and sits on various boards.

Bios_Template_Round.png

Dr. Eric Silver

Director

With extensive experience using medical cannabis to treat chronic pain, Dr. Silver co-founded L.E. Medical in 2002, a nutraceutical and natural health supplement company. Dr. Silver is an Assistant Professor and Clinical Teacher in the Department of Family and Community Medicine at the University of Toronto. He is a member of the College of Family Physicians of Canada, with a focused practice in interventional pain management.



our team

 

EVO_RSCHULTZ_3066.jpg


"let's make cannabis part of a healthy lifestyle embraced everywhere!"


Terry Fretz | Maricann Founder

EVO_RSCHULTZ_2164.jpg